Department of Vascular and Endovascular Surgery, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.
Eur J Vasc Endovasc Surg. 2010 Mar;39(3):349-55. doi: 10.1016/j.ejvs.2009.09.028. Epub 2010 Jan 8.
To evaluate the longterm outcome of venous thrombectomy and simultaneous stenting in patients with acute, symptomatic iliofemoral deep venous thrombosis (DVT).
Between January 1996 and December 2007, a total of 45 patients underwent venous thrombectomy at our institution. Thrombectomy results were classified by intraoperative phlebography as: TYPE I=complete, TYPE II=partial, TYPE III=complete with stenosis other than thrombus, TYPE IV=permanent occlusion. TYPEs I and IV were excluded from this analysis because no endovascular repair was performed. 25 patients underwent a venous hybrid operation comprising balloon-catheter thrombectomy, thrombolysis and stenting of residual stensosis. Three TYPE 2 and 22 TYPE 3 lesions were diagnosed. Three patients died during follow-up from causes unrelated to their treatment. Three were lost to follow-up. Hence, 19 patients were examined. A retrospective, non comparative single-centre study was performed.
Median follow-up was 68 months (range 3-129). Primary and secondary patency rates were 74% (14/19) and 84% (16/19), respectively. Re-thrombosis occurred within seven days of operation in 26% (5/19). Procedure related mortality was zero. There was no case of late re-thrombosis. Four patients showed post-thrombotic sequelae (CEAP: C1, 2 or 3s). No leg ulcer developed in any patient.
Venous thrombectomy with simultaneous stenting results in excellent longterm results in selected patients with symptomatic iliofemoral venous thrombosis.
评估急性症状性髂股深静脉血栓形成(DVT)患者静脉血栓切除术和同期支架置入的长期疗效。
1996 年 1 月至 2007 年 12 月,我院共 45 例患者接受静脉血栓切除术。根据术中静脉造影将血栓切除术结果分为:I 型=完全,II 型=部分,III 型=完全但血栓以外狭窄,IV 型=永久闭塞。由于未进行血管内修复,排除 I 型和 IV 型。25 例患者接受静脉杂交手术,包括球囊导管血栓切除术、溶栓和残余狭窄支架置入。诊断出 3 例 TYPE 2 和 22 例 TYPE 3 病变。3 例患者在随访期间因与治疗无关的原因死亡。3 例失访。因此,19 例患者接受了检查。回顾性、非比较的单中心研究。
中位随访时间为 68 个月(范围 3-129)。一期和二期通畅率分别为 74%(14/19)和 84%(16/19)。26%(5/19)的患者在术后 7 天内再次发生血栓形成。手术相关死亡率为零。无迟发性再血栓形成病例。4 例患者出现血栓后综合征(CEAP:C1、2 或 3s)。无患者发生腿部溃疡。
对于有症状的髂股深静脉血栓形成的患者,静脉血栓切除术同期支架置入可获得良好的长期效果。